The FDA has authorized booster doses of the Pfizer-BioNTech COVID-19 vaccine for kids 5-11.
booster doses of the Pfizer-BioNTech COVID-19 vaccine for kids 5-11, clearing the way for younger Americans to bolster their protection against the coronavirus.The FDA has authorized booster doses of the Pfizer-BioNTech COVID-19 vaccine for kids 5-11 The booster is a 10 microgram dose, the same as the primary vaccine series for the younger age group, which is about a third of what is given to those 12 and older Children in the 5-11 age group can receive their booster shot at least 5 months after their second dose, the FDA saidThe booster is a 10 microgram dose, the same as the primary vaccine series for the younger age group, which is about a third of what is given to those 12 and older.
Children in the 5-11 age group can receive their booster shot at least 5 months after their second dose, the FDA said. "While it has largely been the case that COVID-19 tends to be less severe in children than adults, the omicron wave has seen more kids getting sick with the disease and being hospitalized, and children may also experience longer term effects, even following initially mild disease,” FDA Commissioner Robert Califf said in a statement. "Vaccination continues to be the most effective way to prevent COVID-19 and its severe consequences, and it is safe," he added. "If your child is eligible for the Pfizer-BioNTech COVID-19 Vaccine and has not yet received their primary series, getting them vaccinated can help protect them from the potentially severe consequences that can occur, such as hospitalization and death." The FDA's authorization now heads to the Centers for Disease Control and Prevention before shots can begin getting administered. The CDC's panel of independent advisers, the Advisory Committee on Immunization Practices, will meet Thursday to discuss the boosters before CDC Director Dr. Rochelle Walensky issues her final recommendation. Assuming no changes are made to the FDA's recommendation from the CDC, booster shots could be given as early as Friday. Of the 5-11 age group, only about 30% of those eligible are fully vaccinated against COVID-19. Shots became available for the group in November. In a small study, Pfizer found a booster amplified kids' levels of virus-fighting antibodies -- including those able to fight the omicron variant -- the same kind of jump adults get from an extra shot. While the coronavirus is comparitively more dangerous to adults, kids can get severely ill – more than 350 children ages 5 to 11 have died, according to data from the CDC. Adding to public confusion, the CDC estimates 3 out of every 4 U.S. children of all ages have been infected with the coronavirus since the pandemic’s start – many of them during the winter omicron wave. Still, health authorities urge vaccination even in people who’ve previously had COVID-19 to strengthen their protection against the virus. In the U.S., only one group is not yet eligible for vaccination: Children under 5. Both Pfizer and rival Moderna have been studying their shots in the youngest children, and the FDA is expected to evaluate data from one or both companies sometime next month.
Please follow us on Google to support us United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA authorizes Pfizer Covid booster for children 5 to 11 years oldA study in February found that two doses of the vaccine offered little protection against the omicron variant.
Read more »
FDA authorizes Pfizer COVID-19 booster shots for children ages 5 to 11The FDA has granted emergency use authorization for a booster dose of Pfizer/BioNTech's COVID-19 vaccine for children ages 5 to 11 at least five months after completion of the primary vaccine series.
Read more »
FDA authorizes Pfizer COVID-19 booster shots for children ages 5 to 11The FDA has granted emergency use authorization for a booster dose of Pfizer/BioNTech's COVID-19 vaccine for children ages 5 to 11 at least five months after completion of the primary vaccine series.
Read more »
FDA approves Pfizer COVID booster shots for kids 5 to 11The FDA has granted emergency use authorization for a booster dose of Pfizer/BioNTech's COVID-19 vaccine for children ages 5 to 11.
Read more »
FDA authorizes Pfizer Covid-19 booster shots for children ages 5 to 11The US Food and Drug Administration has granted emergency use authorization for a booster dose of Pfizer/BioNTech's Covid-19 vaccine for children ages 5 to 11 at least five months after completion of the primary vaccine series.
Read more »
FDA authorizes Pfizer COVID-19 booster shots for children ages 5 to 11 -The US Food and Drug Administration has granted emergency use authorization for a booster dose of Pfizer/BioNTech’s Covid-19 vaccine for children ages 5 to 11 at least five months after completion of the primary vaccine series. Pfizer requested this EUA at the end of April, citing company data that showed that a third vaccine dose raised Omicron-fighting antibodies by 36...
Read more »